NCT04737070
Unknown
Not Applicable
Study of High Risk Non Invasive Prenatal Test Population
Central Hospital, Nancy, France0 sites150 target enrollmentFebruary 1, 2021
ConditionsTrisomy 21
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Trisomy 21
- Sponsor
- Central Hospital, Nancy, France
- Enrollment
- 150
- Primary Endpoint
- number of genetics anomalies
- Last Updated
- 5 years ago
Overview
Brief Summary
The investigator want to study the population of high risk (over 1/50) of Trisomy 21.
According to french guidelines, these patients needs to have a invasive test (such as amniocentesis) but some patients prefer to have a Non Invasive Prenatal Test, with a potential lack of information.
Investigators
Matthieu DAP
medical doctor (MD)
Central Hospital, Nancy, France
Eligibility Criteria
Inclusion Criteria
- •Prenatal screening of Trisomy 21 \> 1/50 (high risk population)
Exclusion Criteria
- •No exclusion criteria
Outcomes
Primary Outcomes
number of genetics anomalies
Time Frame: through study completion, an average of 9 months
Similar Trials
Unknown
Not Applicable
Non Invasive Prenatal Diagnosis of Trisomy 21 by Genetic Analysis of Circulating Fetal CellsTrisomy 21NCT01725438Assistance Publique - Hôpitaux de Paris150
Completed
Not Applicable
Reducing False Positives in Prenatal ScreeningPregnancyNCT03375359University Hospital Tuebingen1,127
Unknown
Not Applicable
Non Invasive Prenatal Test of Rare Genetic Diseases: Application to Rare Intellectual DisabilitiesGenetic Disorders in PregnancyNCT03688594University Hospital, Strasbourg, France60
Recruiting
Not Applicable
on invasive prenatal testing (NIPT) of fetal genetic disorders in maternal bloodgenetic disorders10083624NL-OMON50448Medisch Universitair Ziekenhuis Maastricht400
Completed
Not Applicable
Trisomy of Chromosome 21 Diagnosis by High Output SequencingTrisomy 21 - TranslocationNCT01118507Assistance Publique - Hôpitaux de Paris976